Assignee
RIBOSCIENCE LLC
US12 patents
Top patents by PatentIndex Score
US9108999B2Aug 18, 2015
2′, 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC17 citations84
US9370569B2Jun 21, 2016
4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication
RIBOSCIENCE LLC8 citations82
US9249176B2Feb 2, 2016
4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC9 citations82
US10092649B2Oct 9, 2018
4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication
RIBOSCIENCE LLC3 citations71
US9895442B2Feb 20, 2018
4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC2 citations71
US10953030B2Mar 23, 2021
4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC1 citations61
US10682369B2Jun 16, 2020
4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC1 citations61
US11351186B2Jun 7, 2022
4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC1 citations60
US12029744B2Jul 9, 2024
Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
RIBOSCIENCE LLC0 citations57
US9694028B2Jul 4, 2017
4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC0 citations50
US9708357B2Jul 18, 2017
4′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
RIBOSCIENCE LLC0 citations41
US10358458B2Jul 23, 2019
4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication
RIBOSCIENCE LLC0 citations40